A recent Medgadget article discussed the development of a new method for protecting against COVID-19. A team of researchers at McMaster University modified red blood cells in hopes of protecting against future variants. The strategy involves repurposing red blood cells by emptying them out and attaching spike proteins, that mimic a coronavirus, to the outside. The method triggers the immune response without the use of genetic material, which essentially reduces side effects. A video with more information can be seen here.
‘Smart’ Red Blood Cells Could Improve COVID-19 Vaccines
Scientists in Canada modified red blood cells with spike proteins to initiate an immune response against coronaviruses.
Mar 21, 2022
Recommended
Recommended
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
